chronic kidney disease

News

Ardelyx’s-ambition-to-revolutionise-kidney-treatment

EU clears Bayer's chronic kidney disease drug Kerendia

Bayer has claimed EU approval for Kerendia, its new drug for chronic kidney disease (CKD) in people with type 2 diabetes, as the company tries to build a role of the drug alongside rival th

Patients

3D Illustration Concept of Human Urinary System Kidneys Anatomy

Chronic kidney disease: treating a silent killer

In November, NICE backed NHS use of AstraZeneca’s diabetes and heart failure drug Forxiga for the treatment of chronic kidney disease.

News

FDA advisors unconvinced by Reata's kidney disease drug

An FDA advisory committee has delivered a blow to Reata Pharma, after voting unanimously that the drugmaker's data on bardoxolone – a drug for kidney disease – did not show it is effective.

News

Vifor builds in kidney disease with Sanifit, Inositec buys

On the heels of a late-stage clinical trial failure, Vifor Pharma has moved to bolster its pipeline by acquiring Spain's Sanifit and fellow Swiss biotech Inositec for a combined value of €2

News

Cautious welcome as NICE backs Forxiga for chronic kidney di...

Tens of thousands of people with chronic kidney disease in England could be eligible for treatment with AstraZeneca's SGLT2 inhibitor Forxiga, after NICE backed NHS use of the drug in draft

News

Cara's Korsuva is first drug cleared for itching in dialysis...

One of the most common and challenging side effects for people undergoing dialysis for chronic kidney disease – chronic itching – now has an FDA-approved treatment.

EU clears Bayer's chronic kidney disease drug Kerendia

Chronic kidney disease: treating a silent killer

FDA advisors unconvinced by Reata's kidney disease drug

Vifor builds in kidney disease with Sanifit, Inositec buys

Cautious welcome as NICE backs Forxiga for chronic kidney di...

Cara's Korsuva is first drug cleared for itching in dialysis...

NHS use of digital cardiac rehab tools endorsed

How to meet your physicians where they are online

chronic kidney disease

Editor's Picks